Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-03

Clinical Trial Update: Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating two adjuvant chemotherapy regimens—tegafur-uracil with leucovorin and S-1—for patients with stage III colon cancer co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • S-1 (tegafur/gimeracil/oteracil)
  • Tegafur-Uracil and Leucovorin (tegafur-uracil with leucovorin)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED